Quantcast

All Posts Tagged Tag: ‘drug trials’

Merck Drug Fails Major Clinical Trial

Merck, a major U.S. pharmaceutical company, announced this week that its drug “Tredaptive” has failed a clinical trial. The trial was meant to test the drug for its ability to improve patients’ heart health by increasing their levels of “good” cholesterol. The trial, conducted at Oxford University and funded by Merck, looked at 25,673 patients at high risk for heart …

Read More

Diabetes Treatment Drug Shows Encouraging Results in Trials

At the 48th annual meeting of the European Association for the Study of Diabetes (EASD) this week in Berlin, Boehringer Ingelheim Pharmaceuticals, and Eli Lilly announced data from three analyses for linagliptin, a new type 2 diabetes treatment. The studies found that linagliptin lowered hemoglobin A1C in elderly patients with type 2 diabetes and adults with type 2 diabetes and …

Read More

Lung Cancer Drug Trial Cancelled

This week, ArQule, a biotechnology company focused on developing “next-generation” small-molecule cancer drugs, announced that a drug trial for a lung cancer treatment it developed has been stopped early. The independent Data Monitoring Committee (DMC) overseeing the Phase 3 trial recommended that the study be halted following an interim analysis that concluded the trial would not show improved overall survival …

Read More

Cancer Drug Erbitux Fails to Produce Results in Trials

The cancer drug Erbitux, which is manufactured by Merck & Co., Inc, has failed to produce any significant new results for the second month in a row. The German pharmaceutical company, one of the largest in the world, watched helplessly as their wonder drug crashed and burned, ultimately failing in its quest to increase the life span of those patients …

Read More